tiprankstipranks
Trending News
More News >
Neurosense Therapeutics Ltd. (NRSN)
NASDAQ:NRSN
US Market

Neurosense Therapeutics Ltd. (NRSN) Income Statement

Compare
179 Followers

Neurosense Therapeutics Ltd. Income Statement

Last quarter (Q2 2025), Neurosense Therapeutics Ltd.'s total revenue was $0.00, a decrease of ― from the same quarter last year. In Q2, Neurosense Therapeutics Ltd.'s net income was $-2.35M. See Neurosense Therapeutics Ltd.’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 24Dec 23Dec 22Dec 21Dec 20
Total Revenue
$ 0.00$ 0.00$ 0.00$ 0.00$ 0.00
Gross Profit
$ -22.00K$ -97.00K$ -89.00K$ -3.00K$ -3.00K
Operating Expenses
$ 9.88M$ 12.05M$ 13.46M$ 5.59M$ 2.89M
Depreciation and Amortization
$ 22.00K$ 21.00K$ 89.00K$ 3.00K$ 3.00K
EBITDA
$ -9.88M$ -9.64M$ -12.23M$ -2.88M$ -2.83M
Operating Income
$ -9.90M$ -12.05M$ -13.55M$ -5.59M$ -2.89M
Other Income/Expenses
$ -308.00K$ 1.94M$ 1.21M$ 1.55M$ 60.00K
Pretax Income
$ -10.21M$ -11.28M$ -12.34M$ -4.04M$ -2.83M
Net Income
$ -10.21M$ -10.11M$ -12.34M$ -4.04M$ -2.83M
Per Share Metrics
Basic EPS
$ -0.55$ -0.83$ -1.07$ -0.23$ -0.51
Diluted EPS
$ -0.55$ -0.83$ -1.07$ -0.23$ -0.51
Weighted Average Shares Outstanding
18.60M 13.64M 11.51M 10.86M 5.52M
Weighted Average Shares Outstanding (Diluted)
18.60M 13.64M 11.51M 10.86M 5.52M
Currency in USD

Neurosense Therapeutics Ltd. Earnings and Revenue History